$CG Cashflow Statement | Understand Stock

$CG

$38.55 +$0.02 (0.05%) Live

$CG Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Net income (loss)
Consolidated Operating Entities
Total net income (loss)
Adjustments to reconcile net income (loss) to net cash flows from operating activities:
Depreciation and amortization
Consolidated Operating Entities
Total depreciation and amortization
Right-of-use asset impairment, net of broker fees
Consolidated Operating Entities
Total right-of-use asset impairment, net of broker fees
Equity-based compensation
Consolidated Operating Entities
Total equity-based compensation
Non-cash performance allocations and incentive fees, net
Consolidated Operating Entities
Total non-cash performance allocations and incentive fees, net
Non-cash principal investment (income) loss
Consolidated Operating Entities
Total non-cash principal investment (income) loss
Other non-cash amounts
Consolidated Operating Entities
Total other non-cash amounts
Consolidated Funds related:
Realized/unrealized (gain) loss on investments of Consolidated Funds
Realized/unrealized (gain) loss from loans payable of Consolidated Funds
Purchases of investments by Consolidated Funds
Proceeds from sales and settlements of investments by Consolidated Funds
Non-cash interest income, net
Change in cash and cash equivalents held at Consolidated Funds
Change in other receivables held at Consolidated Funds
Change in other liabilities held at Consolidated Funds
Other non-cash amounts of Consolidated Funds
Purchases of investments
Consolidated Operating Entities
Total purchases of investments
Purchase of investment in Fortitude Re
Proceeds from the sale of investments
Consolidated Operating Entities
Total proceeds from the sale of investments
Payments of contingent consideration
Consolidated Operating Entities
Total payments of contingent consideration
Changes in deferred taxes, net
Consolidated Operating Entities
Total changes in deferred taxes, net
Change in due from affiliates and other receivables
Consolidated Operating Entities
Total change in due from affiliates and other receivables
Change in deposits and other
Consolidated Operating Entities
Total change in deposits and other
Change in accounts payable, accrued expenses and other liabilities
Consolidated Operating Entities
Total change in accounts payable, accrued expenses and other liabilities
Change in accrued compensation and benefits
Consolidated Operating Entities
Total change in accrued compensation and benefits
Change in due to affiliates
Consolidated Operating Entities
Total change in due to affiliates
Change in lease right-of-use assets and lease liabilities
Consolidated Operating Entities
Total change in lease right-of-use assets and lease liabilities
Change in deferred revenue
Consolidated Operating Entities
Total change in deferred revenue

Net cash provided by (used in) operating activities
Consolidated Operating Entities
Total net cash provided by (used in) operating activities
Cash flows from investing activities
Purchases of corporate treasury investments
Consolidated Operating Entities
Total purchases of corporate treasury investments
Proceeds from corporate treasury investments
Consolidated Operating Entities
Total proceeds from corporate treasury investments
Purchases of fixed assets, net
Consolidated Operating Entities
Total purchases of fixed assets, net
Purchase of Abingworth, net of cash acquired
Consolidated Operating Entities
Total purchase of Abingworth, net of cash acquired
Purchase of CBAM intangibles and investments
Consolidated Operating Entities
Total purchase of CBAM intangibles and investments
Proceeds from sale, net of cash sold
MRE
Brazil management entity
Net cash used in investing activities
Consolidated Operating Entities
Total net cash used in investing activities
Cash flows from financing activities
Borrowings under credit facilities
Consolidated Operating Entities
Total borrowings under credit facilities
Repayments under credit facilities
Consolidated Operating Entities
Total repayments under credit facilities
Issuance of 4.625% subordinated notes due 2061, net of financing costs
Consolidated Operating Entities
Total issuance of 4.625% subordinated notes due 2061, net of financing costs
Repurchase of 3.875% senior notes due 2023
Consolidated Operating Entities
Total repurchase of 3.875% senior notes due 2023
Repayment of term loan
Consolidated Operating Entities
Total repayment of term loan
Issuance of 5.050% senior notes due 2035, net of financing costs
Consolidated Operating Entities
Total issuance of 5.050% senior notes due 2035, net of financing costs
Proceeds from CLO borrowings, net of financing costs
Consolidated Operating Entities
Total proceeds from CLO borrowings, net of financing costs
Payments on CLO borrowings
Consolidated Operating Entities
Total payments on CLO borrowings
Net borrowings on loans payable of Consolidated Funds
Payments of contingent consideration
Consolidated Operating Entities
Total payments of contingent consideration
Redemption of Preferred Units
Consolidated Operating Entities
Total redemption of Preferred Units
Dividends to common stockholders
Consolidated Operating Entities
Total dividends to common stockholders
Distributions to preferred unitholders
Consolidated Operating Entities
Total distributions to preferred unitholders
Distributions to non-controlling interest holders in Carlyle Holdings
Consolidated Operating Entities
Total distributions to non-controlling interest holders in Carlyle Holdings
Payment of deferred consideration for Carlyle Holdings units
Consolidated Operating Entities
Total payment of deferred consideration for Carlyle Holdings units
Contributions from non-controlling interest holders
Consolidated Operating Entities
Total contributions from non-controlling interest holders
Distributions to non-controlling interest holders
Consolidated Operating Entities
Total distributions to non-controlling interest holders
Common shares issued for performance allocations
Consolidated Operating Entities
Total common shares issued for performance allocations
Common shares repurchased and net share settlement of equity awards
Consolidated Operating Entities
Total common shares repurchased and net share settlement of equity awards
Change in due to/from affiliates financing activities
Consolidated Operating Entities
Total change in due to/from affiliates financing activities
Change in due to/from affiliates and other receivables of Consolidated Funds
Net cash provided by (used in) financing activities
Consolidated Operating Entities
Total net cash provided by (used in) financing activities

Effect of foreign exchange rate changes
Consolidated Operating Entities
Total effect of foreign exchange rate changes
Increase (decrease) in cash, cash equivalents and restricted cash
Consolidated Operating Entities
Total increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash, beginning of period
Consolidated Operating Entities
Total cash, cash equivalents and restricted cash, beginning of period
Cash, cash equivalents and restricted cash, end of period
Consolidated Operating Entities
Total cash, cash equivalents and restricted cash, end of period
Cash and cash equivalents held at Consolidated Funds
Consolidated Operating Entities
Total cash and cash equivalents held at Consolidated Funds
Supplemental cash disclosures
Cash paid for interest
Cash paid for income taxes
Supplemental non-cash disclosures
Issuance of common shares related to the acquisition of CBAM and Abingworth
Tax effects from the conversion to a Corporation recorded in equity
Net increase in partners’ capital and accumulated other comprehensive income related to reallocation of ownership interest in Carlyle Holdings
Net decrease to partners’ capital from deferred consideration for Carlyle Holdings units, net of tax (see Note 10)
Initial consolidation of Consolidated Funds
Net asset impact of deconsolidation of Consolidated Funds
Non-cash distributions to non-controlling interest holders

Deferred tax asset
Tax receivable agreement liability
Total partners’ capital

Reconciliation of cash, cash equivalents and restricted cash, end of period:
Cash and cash equivalents
Consolidated Operating Entities
Total cash and cash equivalents
Restricted cash
Consolidated Operating Entities
Total restricted cash

Comments